Welcome to
Adcock Ingram
Our website offers information about our Company that will give you an understanding of who we are and what we do and how we are building a world class, leading, branded healthcare company. Please contact us should you require any further information on our products or services
to contact us click here
  • Adcock Ingram, a level four B-BBEE pharmaceutical company

  • A leading world-class branded healthcare company

  • Our commitment to quality drives our world-class manufacturing facilities

  • Adding value to life through our Corporate Social Investment programmes

  • Producing pharmaceutical products in the most environmentally friendly way

Latest News

Current News

Africa: Trailblazing African Female Global Health Leaders Receive USP Cepat's Top Honors

...al, FDA Zimbabwe; Member-WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations Malebona Precious Matsoso, Director-General, National Department of Health, South Africa Clavenda Parker, Liberia's first female pharma...

read more..


Des dirigeantes africaines avant-gardistes dans le domaine de la santé mondiale se voient attribuer les récompenses suprêmes de l’USP CePAT

...MS sur la pharmacopee internationale et les preparations pharmaceutiques Malebona Precious Matsoso , directrice generale, Departement national de la sante d’Afrique du Sud Clavenda Parker , première pharmacienne du Liberia et ancienne directrice de la F...

read more..


Trailblazing African Female Global Health Leaders Receive USP CePAT’s Top Honors

...; Member-WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations Malebona Precious Matsoso , Director-General, National Department of Health, South Africa Clavenda Parker , Liberia’s first female pharmacist and forme...

read more..


Finance committee has work cut out

PUBLIC HEARINGS Finance committee has work cut out Linda Ensor Political Writer Parliament's standing committee on finance has an intensive series of public hearings lined up when committees begin work next week, most controversially regarding the constit...

read more..


Pharma forecast: 2017 a big year for generics

A positive outlook on a tough year for business 11 January 2017 According to National Treasury, the GDP growth rate is forecasted at an estimated 1.3% for 2017. The outlook points to a tough year ahead for business; however, there are a few trends that

read more..


Pharma Forecast: 2017 a Big Year for Generics

CEO of Pharma Dynamics, Erik Roos, explains that as generic penetration intensifies, more growth in the sector can be expected in the coming year. > > Amid last year’s unprecedented economic challenges of a weakening rand, fluctuating oil prices and threa...

read more..


Finance committee has work cut out

The committee has called for written submissions on the Fica bill, as well as the sugar tax and insurance bills Parliament’s standing committee on finance has an intensive series of public hearings lined up when committees begin work next week, most contr...

read more..


Medical cannabis – myths vs facts

SAMA warns that the proposed amendments to allow for medical marijuana will be implemented along strict guidelines The South African Medical Association (SAMA) notes the significant developments made in relation to medical cannabis in South Africa. Ho...

read more..


Contact Medical Affairs or report an Adverse Event

To contact medical affairs or to report an adverse event
click here

News and Media

For the latest Adcock Ingram news
click here

Careers

For careers that add value to people’s lives
click here

Financial Results

Online Group Audited Results Booklet 2016
click here

Products

For more information on our products
click here

Financial Indicators

Latest Share Price
4905 cents
Percentage Change: 0.00
Code: AIP
PE Ratio: 21.45
EY: 4.66
DY: 2.12
ZAR/USD: 13.5548
Interim Dividend (cents): 50.00
Final Dividend (cents): 54.00
30 day vwap
N/A cents